TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Seattle Genetics Inc (NASDAQ: SGEN) Investor Securities Class Action Lawsuit 01/10/2017

  • If you purchased shares of Seattle Genetics Inc (NASDAQ: SGEN), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

May 24, 2018 - The court granted defendants' motion to dismiss. January 5, 2018 - Defendants filed a motion to dismiss. November 17, 2017 - The lead plaintiff filed a second amended consolidated complaint on behalf of investors who purchased Seattle Genetics Inc (NASDAQ: SGEN) common shares between October 27, 2016 and December 27, 2016. The lead plaintiff alleges that the defendant...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: